Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20839444 | 1.00 | ALDH1A1 (0.55) | ALDH1A1HPGDKMT2ACA12CA9 | |
| SCHEMBL30762869 | 0.89 | KMT2A (0.58) | ALDH1A1HPGDKMT2AKDM4ERECQL | |
| SCHEMBL20839427 | 0.89 | KMT2A (0.58) | ALDH1A1HPGDKMT2AKDM4ERECQL | |
| SCHEMBL20839425 | 0.89 | ALDH1A1 (0.58) | ALDH1A1HPGDKMT2ACA12CA9 | |
| SCHEMBL30763061 | 0.89 | ALDH1A1 (0.58) | ALDH1A1HPGDKMT2ACA12CA9 | |
| SCHEMBL20839116 | 0.88 | ALDH1A1 (0.57) | ALDH1A1HPGDKMT2ACA12CA9 | |
| SCHEMBL30762876 | 0.88 | ALDH1A1 (0.57) | ALDH1A1HPGDKMT2ACA12CA9 | |
| SCHEMBL20839117 | 0.88 | ALDH1A1 (0.57) | ALDH1A1HPGDKMT2ACA12CA9 | |
| SCHEMBL20839318 | 0.87 | ALDH1A1 (0.48) | ALDH1A1HPGDKMT2AKDM4ERECQL | |
| SCHEMBL30763018 | 0.87 | ALDH1A1 (0.48) | ALDH1A1HPGDKMT2AKDM4ERECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111386261-B | Coumarin derivatives, process for their preparation and their use in the treatment of cancer | 利德发现中心有限责任公司 | 2024-03-22 | — | — | CN | claimed |
| CN-111386261-B | Coumarin derivatives, process for their preparation and their use in the treatment of cancer | 利德发现中心有限责任公司 | 2024-03-22 | — | — | CN | disclosed |